Search

everythinglearnresearchcommunity

for

Search:↓

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Inherited ichthyosis negatively impacts quality of life, affecting daily activities, self-image, and reproductive decisions.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Empowered patients make better healthcare decisions.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hair loss significantly influences medical decisions, affecting treatment choices and emotional well-being.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

Patients with alopecia areata prefer effective, safe, and convenient treatments, especially topical ones.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Patients felt happier with their looks and younger after hair transplant surgery, but their well-being and social life didn't change much.

Doctors must fully inform patients about hair transplant surgery to help them decide and reduce legal issues.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

Patients are interested in anti-aging treatments but rely on dermatologists for guidance.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Patients chose Chinese herbal medicine for safety, relapse prevention, and as an alternative to conventional treatments, but found preparation burdensome.

Facebook groups play a crucial role in supporting and guiding patients on scalp cooling and hair loss during chemotherapy.

Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.

Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.

The document concludes that while some advocate for a patient voucher system, it may be unequal and current healthcare reforms should be given a chance, and it also recommends various medical books for their comprehensive coverage and advice on specific health issues.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Hirsutism affects many women and is managed with a combination of medical treatments and hair removal, tailored to individual needs.